GPCR – structure therapeutics inc. (US:NASDAQ)
Stock Stats
News
Structure Therapeutics to Present Aleniglipron, Amylin and Combination Data at the American Diabetes Association 86th Scientific Sessions
Structure Therapeutics (GPCR) was given a new $101.00 price target by Canaccord Genuity Group Inc..
Structure Therapeutics (GPCR) had its "sell (d-)" rating reaffirmed by Weiss Ratings.
3 Ways to Invest in the Growing GLP-1 Weight Loss Market [Yahoo! Finance]
Structure Therapeutics (GPCR) was upgraded by Wall Street Zen from "s
Form 3 Structure Therapeutics For: Apr 15 Filed by: Lang Matthew
Form 4 Structure Therapeutics For: Apr 15 Filed by: Lang Matthew
Form DEF 14A Structure Therapeutics For: Jun 17
Form ARS Structure Therapeutics For: Dec 31
Form 4 Structure Therapeutics For: Apr 14 Filed by: FMR LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.